Elocon Cream (Elocon Cream)0.1%

$8.25

Each Elocon Cream contains 1% Mometasone Furoate is a steroid medication used to treat certain skin conditions, hay fever, and asthma.

ATC Classification: D07AC13, D07XC03
Active Ingrediant: Mometasone Furoate
Generic Name: Elocon Cream
Manufacturer: Fullford (div. of MSD)
Strength: 0.1%
Dosage Type: Cream
Packaging Type: Tube in Box
Contains: 1 Tube

 

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Elocon Cream (Elocon Cream)0.1%
$8.25

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Mometasone Information


Pronunciation

moe MET a sone

 

What is this drug used for?

• It is used to treat skin irritation.

• It is used to treat skin rashes.

Frequently reported side effects of this drug

• Itching

• Burning

• Stinging

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• High blood sugar like confusion, feeling sleepy, more thirst, hunger, passing urine more often, flushing, fast breathing, or breath that smells like fruit

• Skin changes like pimples, stretch marks, slow healing, or hair growth

• Severe skin irritation

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Elocon lotion may be confused with ophthalmic solutions. Manufacturer’s labeling emphasizes the product is NOT for use in the eyes.

 

Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

 

Adverse Reactions

Central nervous system: Paresthesia, tingling of skin

Dermatologic: Acne rosacea, bacterial skin infection (infants & children), dermatologic disorders, dyschromia (loss of normal skin markings), epidermal thinning, folliculitis (more common with lotion), furunculosis, skin atrophy, stinging of the skin (application site), taut and shiny skin, telangiectasia

Endocrine & metabolic: Decreased cortisol (more common with lotion in infants & children), endocrine disease (lotion)

Gastrointestinal: Xerostomia (infants & children)

Hematologic & oncologic: Bruise

Local: Application site burning, application site pruritus

Rare but important or life-threatening: Acneiform eruption, cataract, cutaneous candidiasis, glaucoma, skin depigmentation –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type